Joanne E Tomassini
8PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial.Dean Follmann, Xiaowei Wang, Lindsey R Baden
|Aug 29, 2024
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.Lindsey R Baden, Hana M El Sahly, Brandon Essink
|Feb 13, 2024
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines.Spyros Chalkias, Nichole McGhee, Jordan L Whatley
|Aug 31, 2023
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results.Spyros Chalkias, Jordan L Whatley, Frank Eder
|Aug 23, 2023
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.Spyros Chalkias, Charles Harper, Keith Vrbicky
|May 10, 2022
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial.Hana M El Sahly, Lindsey R Baden, Brandon Essink
Pageof 2
Frequent Collaborators
2 joint publications
Spyros Chalkias
2 joint publications
Hana M El Sahly
2 joint publications
Darin K Edwards
2 joint publications
Dean Follmann
2 joint publications
Xing Chen
2 joint publications
Stephen Walsh
1 joint publications
Xinwei Sher
1 joint publications
Frances Priddy
1 joint publications
Andrea L Webber
1 joint publications
Nageatte Ibrahim
